MRNA

Moderna, Inc. MRNA

$61.82 -1.33 (-2.11%)

Pullback · -0.91σ

+ Compare Open in Sniper

Price chart

Timeframe

Range

Loading…

Latest bar · MRNA

Momentum reads · latest daily bar

Last

$61.82

-1.33 (-2.11%)

Mkt cap

$24.5B

—

RSI(14)

46.1

neutral

Stochastic %K

18.5

oversold

MFI(14)

59.8

neutral

ADX(14)

30.8

trending

Green means room to run, red means stretched — the reads re-read live as you switch the chart's timeframe. MFI(14) is a volume-weighted money-flow read: above 80 = overbought, below 20 = oversold.

Financial overlay · last 12 quarters

The story behind the price: three years of quarterly results laid over the chart, so you can see whether the stock has been following the business — or running ahead of it.

Quarter	Revenue	Net income	Op income	FCF	Net margin	Op margin
2026-03-31	$0.4B	$-1.3B	$-1.4B	$-0.7B	-345.2%	-356.8%
2025-12-31	$0.7B	$-0.8B	$-0.9B	$0.9B	-122.2%	-126.8%
2025-09-30	$1.0B	$-0.2B	$-0.3B	$-0.9B	-20.0%	-25.9%
2025-06-30	$0.1B	$-0.8B	$-0.9B	$-0.9B	-602.2%	-662.0%
2025-03-31	$0.1B	$-1.0B	$-1.1B	$-1.2B	-907.5%	-981.3%
2024-12-31	$nanB	$nanB	$nanB	$nanB	nan%	nan%

Tip: toggle P/E, FCF, ROE, Gross margin and more on the chart above — every overlay is free.

Compare MRNA vs peers

Line MRNA up against up to 4 peers (5 tickers total) across ~30 metrics and get one weighted 0-100 verdict — best in green, worst in red. Peers also overlay on the chart above as rebased % lines, or flip the chart to the 2×2 grid for side-by-side mini charts.

Comparing MRNA MSFT× AAPL×

Sector peers + SPY + QQQ + DIA

Popular + NVDA + AMZN + GOOG + META + TSLA + AVGO

Matchups NVDA · AMD · AVGO · SMCI · MU AAPL · MSFT · GOOG · META · AMZN JPM · GS · MS · BAC · C TSLA · RIVN · LCID · GM · F XOM · CVX · OXY · COP

Verdict

Weighted score 0-100 across 3 tickers · best in green

MRNA

score 54.6

5/5 inputs

Growth score of 100 dominates with 262% revenue growth, but catastrophic quality drags overall rank to second place.

value 50growth 100quality 17momentum 66sentiment 9

MSFT

score 58.5

5/5 inputs

Sentiment maxes at 100 with 42% analyst upside offsetting zero momentum score from negative year-to-date performance.

value 71growth 50quality 87momentum 0sentiment 100

AAPL

score 36.6

5/5 inputs

Momentum leads at 83 from 27% three-month gain, but zero growth score from slowing fundamentals sinks overall ranking.

value 18growth 0quality 74momentum 83sentiment 28

Metric	MRNA Moderna, Inc.	MSFT Microsoft Corporation	AAPL Apple Inc.
Snapshot
Price	61.82	393.82	333.74
Day %↕	-2.11	-1.82	0.14
1M %↕	11.59	-0.0	11.53
3M %↕	13.06	-6.29	26.7
YTD %↕	100.32	-16.73	23.15
Market cap	24529328128.0	2925466222592.0	4901757779968.0
ADV ($)	479761031.47164917	15501831798.361267	18299230656.54297
Beta	0.942	1.13	1.097
OdysseyHQ zone
Current zone	Pullback	Neutral	Blow-off
Dist 21-EMA %	-6.46	1.16	7.28
Dist ATR (σ)	-0.91	0.37	2.78
OdysseyHQ grade	C	—	—
Confluence↕	3	0	1
Valuation
P/E (ttm)↕	—	23.469606	40.502426
P/E (fwd)↕	-15.033096	20.324642	34.625034
P/S↕	11.024418	9.191689	10.858001
EV/EBITDA↕	-8.97	16.116	30.742
P/B↕	3.312969	7.0606165	45.969696
FCF yield↕	-0.0008	0.0127	0.0206
PEG↕	—	1.21	2.69
Growth
Revenue yoy↕	2.602	0.183	0.166
EPS yoy↕	—	0.234	0.218
FCF yoy↕	—	—	—
Revenue trend 8Q
Quality
Gross margin↕	-0.69888	0.68309	0.47862
Operating margin↕	-1.3110499	0.46326	0.32275
Net margin↕	-1.4355099	0.39341998	0.27152002
ROE↕	-0.36556998	0.34013999	1.4147099
ROA↕	-0.13093	0.14814	0.26229
Debt / Equity↕	0.18	0.3	0.8
Interest cov.↕	-275.8	52.84	—
Technicals
RSI(14)	46.1	51.9	71.6
MACD signal	neutral	neutral	bull
vs 50-DMA	8.29	-1.92	10.27
vs 200-DMA	42.47	-10.36	21.71
vs 52w high	-27.78	-29.1	-0.37
HV-30	90.8	34.3	34.2
Sentiment
Analyst rec↕	2.95652	1.31579	2.0
Target upside↕	-21.93	41.74	-4.64
Insider buy-sell 90d↕	2	20	-5
Risk
Short interest↕	16.399999	1.2	0.9599999499999999
Days to cover↕	6.2	1.84	2.11
Next earnings	2026-07-31	2026-07-29	2026-07-30

MRNA

Moderna, Inc.

$61.82

-2.11%

Snapshot

Price 61.82

Day % -2.11

1M % 11.59

3M % 13.06

YTD % 100.32

Market cap 24529328128.0

ADV ($) 479761031.47164917

Beta 0.942

OdysseyHQ zone

Current zone Pullback

Dist 21-EMA % -6.46

Dist ATR (σ) -0.91

OdysseyHQ grade C

Confluence 3

Valuation

P/E (ttm) —

P/E (fwd) -15.033096

P/S 11.024418

EV/EBITDA -8.97

P/B 3.312969

FCF yield -0.0008

PEG —

Growth

Revenue yoy 2.602

EPS yoy —

FCF yoy —

Revenue trend 8Q

Quality

Gross margin -0.69888

Operating margin -1.3110499

Net margin -1.4355099

ROE -0.36556998

ROA -0.13093

Debt / Equity 0.18

Interest cov. -275.8

Technicals

RSI(14) 46.1

MACD signal neutral

vs 50-DMA 8.29

vs 200-DMA 42.47

vs 52w high -27.78

HV-30 90.8

Sentiment

Analyst rec 2.95652

Target upside -21.93

Insider buy-sell 90d 2

Risk

Short interest 16.399999

Days to cover 6.2

Next earnings 2026-07-31

Full MRNA dashboard →

MSFT

Microsoft Corporation

$393.82

-1.82%

Snapshot

Price 393.82

Day % -1.82

1M % -0.0

3M % -6.29

YTD % -16.73

Market cap 2925466222592.0

ADV ($) 15501831798.361267

Beta 1.13

OdysseyHQ zone

Current zone Neutral

Dist 21-EMA % 1.16

Dist ATR (σ) 0.37

OdysseyHQ grade —

Confluence 0

Valuation

P/E (ttm) 23.469606

P/E (fwd) 20.324642

P/S 9.191689

EV/EBITDA 16.116

P/B 7.0606165

FCF yield 0.0127

PEG 1.21

Growth

Revenue yoy 0.183

EPS yoy 0.234

FCF yoy —

Revenue trend 8Q

Quality

Gross margin 0.68309

Operating margin 0.46326

Net margin 0.39341998

ROE 0.34013999

ROA 0.14814

Debt / Equity 0.3

Interest cov. 52.84

Technicals

RSI(14) 51.9

MACD signal neutral

vs 50-DMA -1.92

vs 200-DMA -10.36

vs 52w high -29.1

HV-30 34.3

Sentiment

Analyst rec 1.31579

Target upside 41.74

Insider buy-sell 90d 20

Risk

Short interest 1.2

Days to cover 1.84

Next earnings 2026-07-29

Full MSFT dashboard →

AAPL

Apple Inc.

$333.74

+0.14%

Snapshot

Price 333.74

Day % 0.14

1M % 11.53

3M % 26.7

YTD % 23.15

Market cap 4901757779968.0

ADV ($) 18299230656.54297

Beta 1.097

OdysseyHQ zone

Current zone Blow-off

Dist 21-EMA % 7.28

Dist ATR (σ) 2.78

OdysseyHQ grade —

Confluence 1

Valuation

P/E (ttm) 40.502426

P/E (fwd) 34.625034

P/S 10.858001

EV/EBITDA 30.742

P/B 45.969696

FCF yield 0.0206

PEG 2.69

Growth

Revenue yoy 0.166

EPS yoy 0.218

FCF yoy —

Revenue trend 8Q

Quality

Gross margin 0.47862

Operating margin 0.32275

Net margin 0.27152002

ROE 1.4147099

ROA 0.26229

Debt / Equity 0.8

Interest cov. —

Technicals

RSI(14) 71.6

MACD signal bull

vs 50-DMA 10.27

vs 200-DMA 21.71

vs 52w high -0.37

HV-30 34.2

Sentiment

Analyst rec 2.0

Target upside -4.64

Insider buy-sell 90d -5

Risk

Short interest 0.9599999499999999

Days to cover 2.11

Next earnings 2026-07-30

Full AAPL dashboard →

Earnings replay · last 20 reports

How this stock actually behaves on report day: each past earnings print with the beat-or-miss and the next-day move — a track record for handicapping the next one.

Date	EPS actual	EPS est	Surprise	Next-day
2026-04-30	-1.18	-3.96	+70.2%	-1.2%
2026-02-13	-2.11	-2.64	+20.2%	+4.0%
2025-11-06	-0.51	-2.16	+76.4%	+0.9%
2025-08-01	-2.13	-3.00	+29.0%	+0.1%
2025-05-01	-2.52	-3.11	+18.9%	+2.1%
2025-02-14	-2.91	-2.73	-6.7%	+8.4%
2024-11-07	0.03	-1.94	+101.5%	-6.9%
2024-08-01	-3.33	-3.35	+0.7%	-8.1%
2024-05-02	-3.07	-3.57	+14.1%	-0.5%
2024-02-22	0.55	-0.99	+155.6%	-3.0%
2023-11-02	-9.53	-2.05	-364.4%	+8.8%
2023-08-03	-3.62	-4.12	+12.2%	-1.6%
2023-05-04	0.19	-1.73	+111.0%	+2.0%
2023-02-23	3.61	4.60	-21.5%	-5.6%
2022-11-03	2.53	3.11	-18.6%	+7.4%
2022-08-03	5.24	4.49	+16.6%	+4.1%
2022-05-04	8.58	5.62	+52.6%	-8.4%
2022-02-24	11.29	9.81	+15.1%	-3.1%
2021-11-04	7.70	9.42	-18.3%	-16.6%
2021-08-05	6.46	5.86	+10.3%	-0.6%

Earnings markers are overlaid on the daily price chart above. Click a ▲ marker for that day's move.

Peer comparison · sector

Context check: the same key numbers for the closest sector names side by side, so you can tell whether this stock is the standout or just moving with its group.

Ticker ⇅	Mkt cap ⇅	P/E ⇅	Fwd P/E ⇅	P/S ⇅	EV/EBITDA ⇅	P/B ⇅	Gross M ⇅	Rev gr ⇅	EPS gr ⇅	FCF yld ⇅
MRNA ★	$25B	—	-15.0	11.0	-9.0	3.3	-69.9%	260.2%	—	-0.08%
SPY	—	26.7	—	—	—	1.7	—	—	—	—
QQQ	—	30.9	—	—	—	1.9	—	—	—	—
DIA	—	24.6	—	—	—	—	—	—	—	—

Auto-seeded from sector. Click any ticker to switch.

Ownership

Who holds the stock and what they've been doing lately — big funds on the left, executives' own buys and sells on the right. Insider buying is the rarer, louder signal.

Top institutional holders

Top-10 concentration: 48.98%

Holder	Shares	% out
FMR, LLC	45,672,024	11.51%
Blackrock Inc.	29,635,876	7.47%
Vanguard Capital Management LLC	22,872,458	5.76%
BAILLIE GIFFORD & CO	19,985,876	5.04%
Capital World Investors	18,697,694	4.71%
Vanguard Portfolio Management LLC	15,616,367	3.94%
State Street Corporation	14,861,409	3.75%
Geode Capital Management, LLC	9,435,132	2.38%
Two Sigma Investments, LP	9,086,404	2.29%
Morgan Stanley	8,471,263	2.13%

Insider activity · 90d

5 buys / 0 sells · ratio 5.0 · Finnhub

McDonnell Michael R. BUY 5,733
McDonnell Michael R. BUY 1,618
McDonnell Michael R. BUY 7,415
Banque Soria Ester BUY 38,364
Banque Soria Ester BUY 18,658
Mock James M M 1,454
Mock James M F 66,436 @ $72.50
Mock James M M 67,139
Klinger Shannon Thyme M 117,976
Klinger Shannon Thyme F 73,561 @ $51.59

Analyst estimates

Finnhub

What Wall Street expects next: the consensus forecasts for the coming quarters. The market usually reacts to results versus these numbers, not the raw results themselves.

Low

$—

Mean

$—

High

$—

Analysts

—

Recommendation distribution · period 2026-07-01

Revision trend (2026-04-01 → 2026-07-01): net -3 → -3 0 (net = strong_buy+buy − sell−strong_sell)

SEC filings

The company's own paperwork, straight from the regulator — annual and quarterly reports, big announcements and insider trades. The primary source behind every headline.

Form	Filed	Description	Action
4	2026-07-16	PRIMARY DOCUMENT	view ·
4	2026-07-10	PRIMARY DOCUMENT	view ·
8-K	2026-07-08	8-K	view ·
4	2026-07-07	PRIMARY DOCUMENT	view ·
4	2026-07-06	PRIMARY DOCUMENT	view ·
4	2026-06-17	PRIMARY DOCUMENT	view ·
4	2026-06-08	PRIMARY DOCUMENT	view ·
4	2026-06-08	PRIMARY DOCUMENT	view ·
4	2026-06-03	PRIMARY DOCUMENT	view ·
4	2026-06-03	PRIMARY DOCUMENT	view ·
4	2026-06-03	PRIMARY DOCUMENT	view ·
4	2026-05-29	PRIMARY DOCUMENT	view ·
4	2026-05-29	PRIMARY DOCUMENT	view ·
4	2026-05-29	PRIMARY DOCUMENT	view ·
4	2026-05-22	4	view ·
4	2026-05-18	PRIMARY DOCUMENT	view ·
8-K	2026-05-11	8-K	view ·
4	2026-05-08	PRIMARY DOCUMENT	view ·
4	2026-05-08	PRIMARY DOCUMENT	view ·
4	2026-05-08	PRIMARY DOCUMENT	view ·
4	2026-05-08	PRIMARY DOCUMENT	view ·
4	2026-05-08	PRIMARY DOCUMENT	view ·
4	2026-05-08	PRIMARY DOCUMENT	view ·
4	2026-05-08	PRIMARY DOCUMENT	view ·
4	2026-05-04	PRIMARY DOCUMENT	view ·
4	2026-05-04	PRIMARY DOCUMENT	view ·
4	2026-05-04	PRIMARY DOCUMENT	view ·
4	2026-05-04	PRIMARY DOCUMENT	view ·
4	2026-05-04	PRIMARY DOCUMENT	view ·
4	2026-05-04	PRIMARY DOCUMENT	view ·
10-Q	2026-05-01	10-Q	view ·
8-K	2026-05-01	8-K	view ·
4	2026-04-06	PRIMARY DOCUMENT	view ·
DEF 14A	2026-03-16	DEFINITIVE PROXY STATEMENT	view ·
4	2026-03-06	PRIMARY DOCUMENT	view ·
4	2026-03-06	PRIMARY DOCUMENT	view ·
8-K	2026-03-05	8-K	view ·
4	2026-03-03	PRIMARY DOCUMENT	view ·
4	2026-03-03	PRIMARY DOCUMENT	view ·
4	2026-03-03	PRIMARY DOCUMENT	view ·
4	2026-03-03	PRIMARY DOCUMENT	view ·
4	2026-02-25	PRIMARY DOCUMENT	view ·
10-K	2026-02-20	10-K	view ·
4	2026-02-13	PRIMARY DOCUMENT	view ·
4	2026-02-13	PRIMARY DOCUMENT	view ·
4	2026-02-13	PRIMARY DOCUMENT	view ·
4	2026-02-13	PRIMARY DOCUMENT	view ·
8-K	2026-02-13	8-K	view ·
8-K	2026-02-11	8-K	view ·
8-K	2026-01-12	8-K	view ·
4	2026-01-06	PRIMARY DOCUMENT	view ·
8-K	2026-01-05	8-K	view ·
4	2025-12-15	4	view ·
4	2025-12-15	PRIMARY DOCUMENT	view ·
4	2025-12-11	PRIMARY DOCUMENT	view ·
4	2025-12-08	PRIMARY DOCUMENT	view ·
4	2025-12-08	PRIMARY DOCUMENT	view ·
4	2025-12-02	PRIMARY DOCUMENT	view ·
4	2025-12-02	PRIMARY DOCUMENT	view ·
4	2025-12-01	PRIMARY DOCUMENT	view ·

About MRNA

No company description available.

Options picks · MRNA

ITM + OTM ideas from the latest scan

Loading…

Congress trades · MRNA

STOCK Act disclosures

Loading…

SEC filings & insiders · MRNA

EDGAR · live

Loading…

Holders · MRNA

Institutions & insider activity

Loading…

Moderna, Inc. MRNA

Price chart

Latest bar · MRNA

Financial overlay · last 12 quarters

Compare MRNA vs peers

Earnings replay · last 20 reports

Peer comparison · sector

Ownership

Top institutional holders

Insider activity · 90d

Analyst estimates

SEC filings

About MRNA

Options picks · MRNA

Congress trades · MRNA

SEC filings & insiders · MRNA

Holders · MRNA

Filing summary